Cost-efficient and Accurate Risk Assessment Instruments in Type 2 Diabetics with Greatest Risk for Cardiovascular Disease. ccm. 2026;10(2):71-78. Accessed September 17, 2026. https://fortunejournals.org/ojs/index.php/ccm/article/view/16687